Stock Market & Financial Investment News

News Breaks February 5, 2013 06:36 EDT RPRX Repros Therapeutics initiated with a Buy at Lazard Capital Target $26. News For RPRX From The Last 14 Days Check below for free stories on RPRX the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 10, 2013 09:26 EDT RPRX Repros Therapeutics reports Q1 EPS (41c), consensus (35c) Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.